Recommended Global Infectious Diseases Webinars & Conferences
Asia Pacific & Middle East
INFECTIOUS DISEASES2026
Welcome Message
Welcome to the 7th International Conference on Microbiology and Infectious Diseases, scheduled for November 04–05, 2026 in Barcelona, Spain, under the theme of “Advancing Global Health Through Innovations in Microbiology and Infectious Disease Research.” This prestigious gathering brings together experts, researchers, clinicians, academicians, and healthcare professionals from across the globe to discuss the latest developments in microbiology and infectious diseases.
The conference will focus on emerging trends in infectious disease prevention, diagnosis, treatment, antimicrobial resistance, virology, bacteriology, immunology, and public health strategies. Participants will have the opportunity to present their research, share innovative ideas, and explore cutting-edge technologies that are shaping the future of global healthcare and disease control.
Through keynote sessions, scientific presentations, panel discussions, and networking opportunities, the event aims to foster collaboration and knowledge exchange among international experts. We warmly invite you to join us in Barcelona to contribute to scientific advancement and work together toward improving global health outcomes.
The conference also aims to encourage young researchers and students by providing them with a platform to showcase their work and gain valuable insights from experienced professionals. It serves as a unique opportunity to build international collaborations, foster innovation, and strengthen research networks that will contribute to advancing microbiology and infectious disease studies worldwide.
About Infectious Diseases 2026
Infectious Diseases 2026 is a global scientific platform dedicated to advancing research, innovation, and collaboration in the field of infectious diseases. The event brings together leading microbiologists, virologists, immunologists, clinicians, researchers, and public health experts to discuss the latest breakthroughs in disease prevention, diagnosis, treatment, and control. It serves as an important forum for addressing current and emerging global health challenges caused by infectious agents.
The conference focuses on key areas such as emerging and re-emerging infectious diseases, antimicrobial resistance, epidemiology, vaccine development, viral infections, bacterial infections, parasitic diseases, and advancements in diagnostic technologies. It also highlights public health strategies, infection control measures, and global surveillance systems aimed at improving preparedness and response to disease outbreaks.
Infectious Diseases 2026 provides a valuable opportunity for participants to present their research, exchange scientific knowledge, and explore innovative approaches in healthcare. Through keynote lectures, oral presentations, poster sessions, and networking activities, the event fosters international collaboration and encourages new ideas that contribute to strengthening global health systems and improving patient outcomes.
Why to Attend Infectious Diseases 2026
- Gain insights into the latest research and innovations in infectious diseases, microbiology, virology, and immunology.
- Learn about emerging trends in disease prevention, diagnosis, treatment, and global health management.
- Explore advancements in antimicrobial resistance, vaccine development, and infectious disease control strategies.
- Present your research work and receive valuable feedback from international experts and peers.
- Network with scientists, clinicians, academicians, and healthcare professionals from around the world.
- Build collaborations for future research projects, publications, and academic opportunities.
- Participate in keynote lectures, oral presentations, and poster sessions led by global leaders.
- Enhance knowledge of public health policies, outbreak management, and global disease surveillance systems.
- Support career growth by engaging with industry experts and leading research organizations.
- Contribute to advancing global health solutions and improving patient care outcomes worldwide.
Target Audience
- Microbiologists and clinical microbiologists
- Infectious disease specialists and physicians
- Virologists, bacteriologists, and immunologists
- Epidemiologists and public health researchers
- Biomedical scientists and laboratory professionals
- Academicians, professors, and research scholars
- Medical students, PhD scholars, and young researchers
- Pharmacologists and vaccine researchers
- Healthcare professionals and hospital practitioners
- Biotechnology and pharmaceutical industry professionals
- Public health organizations and healthcare policymakers
- Diagnostic laboratory experts and pathologists
- NGOs and global health organizations working in disease control
- Clinical researchers and trial investigators
Sessions & Tracks
Session 01: Advances in Clinical Microbiology and Diagnostic Technologies
Clinical microbiology is fundamental to the diagnosis, treatment, and prevention of infectious diseases. Continuous advances in laboratory science have transformed diagnostic practices by enabling faster, more accurate, and highly sensitive detection of bacterial, viral, fungal, and parasitic pathogens. This session focuses on emerging technologies that are reshaping clinical microbiology and improving patient care. Topics include conventional microbiological methods, culture-based diagnostics, microscopy, biochemical testing, antimicrobial susceptibility testing, and quality assurance in clinical laboratories. The session also explores molecular diagnostic techniques such as polymerase chain reaction (PCR), real-time PCR, multiplex PCR, digital PCR, next-generation sequencing (NGS), metagenomics, and whole-genome sequencing for pathogen identification and antimicrobial resistance detection. Participants will examine laboratory automation, artificial intelligence, machine learning, digital microbiology, biosensors, and point-of-care diagnostic technologies that support rapid clinical decision-making. Discussions will cover biosafety, biosecurity, laboratory accreditation, specimen management, quality control, disease surveillance, outbreak investigations, and integration of laboratory findings with public health systems. The session provides comprehensive insights into modern diagnostic innovations that are enhancing precision medicine, improving laboratory efficiency, and strengthening infectious disease surveillance worldwide.
Session 02: Emerging Infectious Diseases, Antimicrobial Resistance, and Global Health
Emerging infectious diseases and antimicrobial resistance continue to present major challenges to healthcare systems and global public health. This session explores the epidemiology, transmission, prevention, and control of emerging and re-emerging pathogens affecting human populations worldwide. Topics include viral, bacterial, fungal, parasitic, and zoonotic diseases, outbreak preparedness, pandemic response, environmental influences on disease emergence, and global surveillance systems. A major focus is placed on antimicrobial resistance, including resistance mechanisms, multidrug-resistant organisms, genomic surveillance, antimicrobial susceptibility testing, and the impact of inappropriate antimicrobial use in healthcare, agriculture, and veterinary medicine. Participants will examine antimicrobial stewardship programs, infection prevention strategies, evidence-based prescribing practices, and international policies designed to combat resistant pathogens. The session also highlights the One Health approach, recognizing the interconnected roles of human, animal, and environmental health in preventing infectious diseases. Advances in vaccine development, molecular epidemiology, public health preparedness, and collaborative international research will also be discussed. This session offers a comprehensive overview of current challenges and innovative solutions for improving global health security, strengthening surveillance systems, and advancing effective prevention, diagnosis, and management of infectious diseases.
Session 03: Medical Microbiology and Host–Pathogen Interactions
Medical microbiology investigates the complex relationships between microorganisms and their human hosts. Understanding host–pathogen interactions is fundamental to explaining disease progression, immune responses, and treatment outcomes. This session explores microbial virulence factors, mechanisms of infection, immune evasion strategies, and host defense systems. Topics include bacterial toxins, viral replication, fungal pathogenicity, parasitic infections, innate and adaptive immunity, inflammatory responses, and immune-mediated tissue damage. Advances in molecular biology and immunology have improved our understanding of microbial pathogenesis, leading to innovative therapeutic approaches and preventive strategies. Discussions will also examine biomarkers of infection, personalized medicine, and translational research that bridges laboratory discoveries with clinical applications.
Session 04: Antimicrobial Resistance and Stewardship
Antimicrobial resistance remains one of the greatest challenges facing global healthcare. This session focuses on the emergence, spread, and control of resistant microorganisms across clinical and community settings. Topics include resistance mechanisms, antimicrobial susceptibility testing, genomic surveillance, multidrug-resistant pathogens, stewardship programs, responsible prescribing practices, and infection prevention strategies. Participants will discuss global surveillance initiatives, novel antimicrobial development, and evidence-based policies designed to preserve the effectiveness of existing therapies while improving patient outcomes.
Session 05: Virology and Viral Infectious Diseases
Viruses continue to cause significant global health challenges through outbreaks, pandemics, and chronic infections. This session examines viral biology, replication mechanisms, pathogenesis, laboratory diagnostics, antiviral therapies, and vaccine development. Discussions include respiratory viruses, hepatitis viruses, human immunodeficiency virus, emerging zoonotic viruses, arboviruses, and novel viral variants. Participants will explore molecular surveillance, viral evolution, immune responses, and strategies for outbreak preparedness and disease prevention.
Session 06: Bacteriology and Bacterial Pathogenesis
Bacterial pathogens remain major causes of infectious diseases worldwide. This session highlights bacterial physiology, taxonomy, virulence mechanisms, biofilm formation, quorum sensing, antimicrobial susceptibility, and laboratory identification techniques. Emerging bacterial pathogens, healthcare-associated infections, foodborne illnesses, and community-acquired infections will be discussed. Advances in bacterial genomics, rapid diagnostics, and novel antibacterial therapies will also be presented.
Session 07: Mycology and Fungal Infections
Fungal infections have become increasingly important due to rising numbers of immunocompromised patients and emerging resistant fungi. This session covers medical mycology, fungal diagnostics, antifungal susceptibility testing, invasive fungal diseases, opportunistic infections, and advances in antifungal therapies. Participants will examine fungal epidemiology, host immune responses, environmental fungi, and strategies for improving diagnosis and management of fungal infections.
Session 08: Parasitology and Tropical Diseases
Parasitic infections remain major contributors to global morbidity and mortality, particularly in tropical and subtropical regions. This session explores protozoan and helminth infections, vector-borne diseases, laboratory diagnosis, epidemiology, parasite biology, host immunity, and disease control programs. Advances in molecular diagnostics, vaccine development, and integrated parasite management strategies will also be discussed.
Session 09: Infection Prevention and Control
Preventing healthcare-associated infections is essential for patient safety and healthcare quality. This session examines infection prevention practices, hospital epidemiology, sterilization, disinfection, environmental hygiene, surveillance systems, isolation precautions, and healthcare worker safety. Participants will discuss evidence-based infection control guidelines, outbreak investigations, and quality improvement initiatives aimed at reducing healthcare-associated infections.
Session 10: Vaccines and Immunization Strategies
Vaccination has transformed global public health by preventing numerous infectious diseases. This session focuses on vaccine research, immunology, vaccine development technologies, clinical trials, vaccine safety, immunization programs, and public health implementation. Emerging vaccine platforms, including mRNA and recombinant technologies, as well as strategies to improve vaccine acceptance and equitable distribution, will be explored.
Session 11: Molecular Microbiology and Microbial Genomics
Molecular microbiology has revolutionized the understanding of microbial genetics, evolution, and disease mechanisms. This session discusses microbial genomics, transcriptomics, proteomics, gene regulation, genome editing, metagenomics, and bioinformatics applications. Participants will examine how molecular technologies support disease diagnosis, antimicrobial resistance surveillance, outbreak investigations, and precision medicine.
Session 12: Zoonotic and Emerging Infectious Diseases
Many infectious diseases originate from animals before spreading to human populations. This session explores zoonotic pathogens, wildlife reservoirs, vector-borne transmission, environmental drivers, and One Health approaches. Topics include emerging epidemics, surveillance systems, risk assessment, climate change impacts, and interdisciplinary collaboration for preventing future outbreaks.
Session 13: Food, Water, and Environmental Microbiology
Environmental microorganisms significantly influence human health through food, water, and ecological systems. This session focuses on foodborne pathogens, waterborne diseases, environmental surveillance, sanitation, microbial contamination, food safety regulations, wastewater monitoring, and environmental microbiology techniques. Discussions include microbial ecology and strategies for protecting public health.
Session 14: Microbiome Research and Human Health
The human microbiome plays a critical role in maintaining health and influencing disease susceptibility. This session examines the composition and function of microbial communities within the gut, skin, respiratory tract, and other body sites. Topics include microbiome sequencing, microbial dysbiosis, probiotics, prebiotics, metabolomics, and microbiome-based therapeutics for infectious and chronic diseases.
Session 15: Public Health Microbiology and Disease Surveillance
Public health microbiology supports disease prevention through laboratory surveillance, outbreak detection, and epidemiological investigations. This session covers surveillance systems, laboratory networks, molecular epidemiology, data integration, public health reporting, and emergency preparedness. Participants will discuss strategies for strengthening laboratory capacity and improving global health security.
Session 16: Pediatric and Geriatric Infectious Diseases
Age influences susceptibility, diagnosis, treatment, and prevention of infectious diseases. This session focuses on infections affecting newborns, children, older adults, and immunocompromised individuals. Topics include vaccination strategies, antimicrobial therapy, age-related immune responses, healthcare-associated infections, and management of vulnerable populations.
Session 17: Diagnostic Innovations and Point-of-Care Testing
Rapid diagnostic technologies are transforming infectious disease management. This session explores biosensors, portable diagnostic devices, molecular assays, laboratory automation, digital pathology, artificial intelligence, and point-of-care testing. Discussions emphasize improving diagnostic accessibility, reducing turnaround times, and supporting clinical decision-making in diverse healthcare settings.
Session 18: Biotechnology, Therapeutics, and Drug Discovery
Advances in biotechnology continue to accelerate the development of innovative therapies for infectious diseases. This session examines antimicrobial drug discovery, monoclonal antibodies, bacteriophage therapy, antimicrobial peptides, gene-based therapeutics, nanotechnology, and translational research. Participants will discuss strategies for overcoming antimicrobial resistance and developing next-generation therapeutics.
Session 19: One Health and Global Infectious Disease Preparedness
The One Health concept recognizes the interconnected health of humans, animals, and ecosystems. This session focuses on interdisciplinary approaches to disease surveillance, antimicrobial resistance, zoonotic disease prevention, environmental monitoring, and emergency preparedness. Participants will examine collaborative strategies that strengthen global responses to emerging infectious threats.
Session 20: Future Perspectives in Microbiology and Infectious Disease Research
Rapid advances in science and technology continue to reshape microbiology and infectious disease research. This session explores emerging technologies, precision medicine, artificial intelligence, synthetic biology, systems microbiology, advanced vaccine platforms, digital health, and global research collaborations. Discussions will identify future challenges, innovative research directions, and opportunities for translating scientific discoveries into improved clinical care, public health practice, and sustainable infectious disease control.
Abstract Submission Guidelines
Researchers, academicians, clinicians, industry professionals, and students are invited to submit original research, case studies, systematic reviews, and innovative findings related to Microbiology and Infectious Diseases. All abstracts will undergo a peer-review process conducted by the Scientific Committee to ensure scientific quality, originality, and relevance to the conference themes.
Submission Guidelines
- Abstracts must be original and should not have been previously published or presented at another conference.
- The abstract should be written in clear English.
- Word limit: 250–300 words (excluding title and author information).
-
Include the following sections:
- Title
- Author(s) and Affiliation(s)
- Background
- Objectives
- Methods
- Results
- Conclusion
- Keywords (3–5)
- Tables, figures, and references are not required in the abstract.
- Authors should indicate their preferred presentation format (Oral or Poster).
- All submissions must be made through the conference abstract submission portal.
- Accepted abstracts will be published in the conference proceedings or abstract book.
Important Dates
| Activity | Date |
|---|---|
| Abstract Submission Opens | January 20,2026 |
| Abstract Submission Deadline |
November 02, 2026 |
| Notification of Acceptance | Within 2-3 days |
| Early Bird Registration Deadline | July 20, 2026 |
| Final Registration Deadline |
November 04, 2026 |
| Conference Dates |
November 04-05, 2026 |
Registration is mandatory for all participants, presenters, speakers, and delegates. Each accepted abstract must have at least one registered author to be included in the conference program and proceedings.
Registration Categories
- Speaker Registration
- Delegate Registration
- Student Registration
- Poster Presenter Registration
- Virtual Presenter Registration
- Industry/Corporate Participant
Participation Options
Participants can choose from the following presentation formats:
- Oral Presentation – Present research during scientific sessions.
- Poster Presentation – Display research findings in the poster exhibition.
- Virtual Presentation – Present online through the conference platform.
- Listener/Delegate – Attend all scientific sessions without presenting.
- Workshop Participation – Participate in specialized workshops and training sessions.
- Exhibitor/Sponsor – Showcase products, technologies, or services to an international audience.
Registration Link
Register Here:
https://infectiousdiseases.microbiologyconferences.com/registration.php
Abstract Submission Link
Submit Your Abstract:
https://infectiousdiseases.microbiologyconferences.com/abstract-submission.php
Contact Us
Conference Secretariat
Microbiology and Infectious Diseases Conference
Email: [email protected]
Phone: +44 2880090005
Website:https://infectiousdiseases.microbiologyconferences.com/
Why Participate?
- Present your latest research to an international audience.
- Network with leading scientists, clinicians, and healthcare professionals.
- Learn about the latest advances in microbiology and infectious diseases.
- Receive constructive feedback from experts.
- Publish accepted abstracts in the conference proceedings.
- Explore collaboration, funding, and career opportunities.
- Earn a certificate of participation and presentation.
Market Analysis
The global Microbiology and Infectious Diseases market is experiencing substantial growth, driven by increasing infectious disease outbreaks, antimicrobial resistance (AMR), technological advancements in diagnostics, expanding biotechnology research, and rising investments in healthcare infrastructure. The lessons learned from recent global pandemics have accelerated funding for microbiology research, laboratory modernization, vaccine development, and infectious disease surveillance. Governments, healthcare organizations, and pharmaceutical companies continue to prioritize rapid diagnostics, genomic sequencing, and innovative therapeutic solutions to strengthen preparedness against future infectious threats.
The global clinical microbiology market was valued at approximately USD 6.5 billion in 2024 and is projected to reach USD 11.8–12.5 billion by 2032, expanding at a compound annual growth rate (CAGR) of approximately 7.5–8.5%. This growth is fueled by increasing adoption of molecular diagnostics, automation in microbiology laboratories, next-generation sequencing (NGS), and artificial intelligence-enabled diagnostic platforms.
The broader infectious disease diagnostics market is also expanding rapidly. Valued at nearly USD 25 billion in 2024, it is expected to exceed USD 40 billion by 2032, growing at a CAGR of around 6–7%. Demand is increasing for rapid molecular testing, multiplex PCR assays, point-of-care diagnostics, and digital health technologies that enable early disease detection and effective patient management.
The antimicrobial resistance (AMR) diagnostics and therapeutics market represents one of the fastest-growing segments within infectious disease research. Global initiatives to combat drug-resistant pathogens have significantly increased investments in antimicrobial stewardship programs, novel antibiotics, bacteriophage therapies, antimicrobial peptides, and genomic surveillance technologies. The AMR market is anticipated to achieve USD 15–18 billion by 2032, supported by strong public and private funding.
Vaccine research and development continue to be major growth drivers. The success of mRNA vaccine platforms has accelerated investment in next-generation vaccines targeting respiratory viruses, antimicrobial-resistant bacteria, emerging zoonotic pathogens, and neglected tropical diseases. Continuous innovation in vaccine technologies is expected to create significant opportunities for biotechnology companies, pharmaceutical manufacturers, and academic institutions.
Artificial intelligence, bioinformatics, and digital microbiology are transforming infectious disease diagnosis and surveillance. AI-assisted image analysis, laboratory automation, predictive outbreak modeling, and genomic data interpretation are improving diagnostic accuracy while reducing turnaround time. Integration of cloud-based laboratory information systems and real-time surveillance networks is expected to further strengthen disease monitoring capabilities worldwide.
The Asia-Pacific region is projected to experience the fastest market growth during the forecast period due to expanding healthcare infrastructure, increasing government investments in biomedical research, growing biotechnology industries, and rising awareness of infectious disease prevention. Countries such as China, India, Japan, South Korea, and Singapore are investing heavily in advanced microbiology laboratories, genomic sequencing facilities, vaccine manufacturing, and public health surveillance systems. North America continues to dominate the global market due to its strong pharmaceutical industry, well-established research institutions, and high adoption of advanced diagnostic technologies, while Europe maintains significant market share through robust public health programs and collaborative research initiatives.
Future Outlook
Over the next decade, microbiology and infectious disease research will increasingly focus on precision diagnostics, genomic surveillance, antimicrobial resistance management, AI-driven laboratory systems, microbiome research, vaccine innovation, and One Health approaches. Rising investments in biotechnology, personalized medicine, and global disease surveillance are expected to sustain long-term market growth. The increasing collaboration among academic institutions, healthcare providers, pharmaceutical companies, and public health agencies will continue to drive innovation and strengthen global preparedness against existing and emerging infectious diseases.
Past Conference Report
INFECTIOUS DISEASES2025
Welcome to the 5th International Conference on Microbiology and Infectious Diseases, set to take place on June 16-17, 2025, in the vibrant city of Amsterdam, Netherlands. We are excited to bring together leading microbiologists, infectious disease experts, and healthcare professionals from around the globe. This event is designed to foster insightful discussions and share cutting-edge research, advancements, and techniques within the field of microbiology and infectious diseases.
Our program covers a comprehensive array of topics, from novel microbial diagnostics and innovative antimicrobial therapies to insights into emerging infectious diseases and updated infection control protocols. Renowned speakers and industry leaders will provide invaluable perspectives, sparking discussions that lead to deeper understanding and fresh collaborations.
We aim to provide a supportive, inclusive, and engaging environment where participants can connect, share expertise, and strengthen professional networks. Whether you're seeking the latest research, eager to engage with peers, or looking to form new collaborations, the 5th International Conference on Microbiology and Infectious Diseases promises a rewarding experience for all attendees. Join us in Amsterdam as we come together to shape the future of microbiology and infectious disease management.
Past Reports Gallery
To Collaborate Scientific Professionals around the World
Conference Date November 04-05, 2026
For Sponsors & Exhibitors
Speaker Opportunity
Useful Links
Supported By
All accepted abstracts will be published in respective Conference Series International Journals.
Abstracts will be provided with Digital Object Identifier by